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The co-Editors-in-Chief of Environmental Health respond to an unusual initiative taken by editors of 14 toxicology
journals to influence pending decisions by the European Commission to establish a framework for regulating
chemicals that pose a hazard to normal function of the endocrine system. This initiative is also the subject of this
Commentary in this journal by authors who recently reviewed the subject and who point out inaccuracies in the
toxicology editors’ critique. The dispute is about potential public policy development, rather than on science
translation and research opportunities and priorities. The toxicology journal editors recommend that chemicals be
examined in depth one by one, ignoring modern achievements in biomedical research that would allow new
understanding of the effects of classes of toxic substances in complex biological systems. Concerns about policy
positions framed as scientific ones are especially important in a time with shrinking public support for biomedical
research affects priorities. In such a setting, conflict of interest declarations are important, especially in research
publications that address issues of public concern and where financial and other interests may play a role. Science
relies on trust, and reasonable disclosure of financial or other potential conflicts is therefore essential. This need has
been emphasized by recent discoveries of hidden financial conflicts in publications in toxicology journals, thus
misleading readers and the public about the safety of particular industrial products. The transparency provided by
Environmental Health includes open access and open peer review, with reader access to reviews, including the identity
of reviewers and their statements on possible conflicts of interest. However, the editors of the 14 toxicology journals
did not provide any information on potential conflicts of interest, an oversight that needs to be corrected.
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In a Commentary published in this journal, Bergman
et al. [1] respond to a highly unusual coor-dinated set of
identical editorials in 14 toxicology journals, now avail-
able ahead-of-print [2]. The parallel editorials in these
scientific journals are not about specific research find-
ings, nor existing science-based public policy. Instead
they are written with the sole purpose of influencing
pending policy decisions of the European Commission.
At stake is the future regulatory framework for industrial
chemicals suspected of affecting functions of the human* Correspondence: pgrand@sdu.dk
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distribution, and reproduction in any mediumendocrine system, a key player in development and
physiological function and also a key to the pathogenesis
of important non-communicable diseases [3,4].
The essence of the position of the toxicology journal
editors is that there is insufficient evidence to justify
any new regulation regarding effects of chemicals on
the endocrine system. They further endorse the gen-
eral strategy that risk assessments of the tens of thou-
sands of untested chemicals be conducted separately
for each, one at a time. This conclusion reminds us of
the unfortunate advice another group of toxicology ex-
perts gave more than 20 years ago in regard to develop-
mental toxicology: “Differences in sensitivity between
children and adults are chemical specific and must be
studied and evaluated on a case-by-case basis” [5]. The
reluctance to accept that children and the fetus are
often much more vulnerable to toxicants than areed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and mercury, was delayed by many years, if not decades,
thereby causing harm to untold numbers of children [6].
We are concerned that such advocacy of particular solu-
tions belongs within the policy-development realm, not
within toxicology or the science-based translation of toxi-
cology, notwithstanding the fact that the editorial is written
by editors of science journals.
Dietrich et al. assert (without supporting citation) that the
proposed legal framework deliberately ignores or is ignorant
of time-tested principles of the science of toxicology that
have been universally accepted for centuries [2]. They offer
as their model the early 20th century whole organism assay
(either human or laboratory animal) that was the mainstay
of a much older generation of toxicologists. This view was
prevalent before the discovery and deciphering of the gen-
etic code and before the first hormone protien was
sequenced (1953) or radioimmunoassay (1960) ushered in
a new era in endocrinology. At about the same time, com-
partment analysis and mathematical modeling of systems
with feedback loops became possible, but the more compli-
cated biological systems remained relatively intractable until
methods for qualitative analysis of systems of coupled non-
linear differential equations and chaotic systems became
prevalent starting in the 1980s. Recently these analytical
methods have been linked with modern genomics, epigenet-
ics, and microanalysis of biological compounds, thereby
revealing a New World of effects and consequences unfore-
seen by classical toxicology.
Modern endocrinology has therefore seen a paradigm
change prompted by modern methods of science. How-
ever, the view of the editors of the journals represented by
Dietrich et al. [2] appears to be stuck in the last century,
before recent scientific achievements. The authors seem to
have missed the great advantages of computational chem-
istry, gene expression and receptor binding assays, knock-
out animal models, and many other accomplishments that
now inform modern endocrinology. Dietrich et al. still pro-
mote a focus on individual substances to generate solid
understanding of each of their properties in isolation only
on whole organisms, rather than utilizing our new under-
standing of the effects of toxic substances in complex bio-
logical systems.
Thus, the methods and teachings that underlie the edi-
torial by Dietrich et al. [2], while not cited, are implicitly
the methods and teaching of a previous generation of toxi-
cologists. They also bear no relation to modern endocrin-
ology, which may not be published in toxicology journals
but in other specialty journals. As the Commentary by
Bergman et al. [1] points out, to make matters worse, in
our view the journal editors also misstate the scientific
positions of the European Commission, WHO and nu-
merous other international bodies that have considered
this matter.But the editorial by Dietrich et al. [2] is not really about
science, whether contemporary or old fashioned. It is ex-
plicitly about public policy. It can conflate the two only by
claiming the science as settled, a product of centuries of ac-
cepted methods and established teaching, although it gives
no evidence to substantiate this sweeping and inaccurate
claim. While the science that comprises the context of the
pending Commission decisions is modern, the public pol-
icy question is not: it is the problem of taking important
decisions in the face of varying levels of uncertainty [7].
Unlike Dietrich et al., we acknowledge that this uncer-
tainty exists. It is the responsibility of policy makers, not
scientists, to shape the policy in a way that the net benefit
is positive and maximized, taking account of societal
values and norms. Such decisions have potential economic
and societal consequences. Often industry and society
adapt and the disadvantages are minor, perhaps even pro-
moting innovation to the benefit of industry, as suggested
in a recent commentary on climate change [8]. Dietrich
et al. [2] assume that the consequences are “profound,”
but give no evidence to support their black-and-white
view.
Apart from these differences in perspectives, there are
some important links to science policy that should not be
left uncommented upon. The demand that chemicals be
considered one at a time comes in a context where public
funding for research is contracting. In the EU, the plans
for Horizon 2020 suggest that the funding for biomedical
research will fall while it becomes even more focused, and
the US biomedical research budget is shrinking for the
first time in its history. Private corporations are at the
same time voicing concerns about the burden of having to
test their chemical products. In this context, the arduous
and time-consuming task of chemical-by-chemical evalu-
ation by classical standards of toxicology is not just a delay
in providing vital information about the safety of our en-
vironment but, practically speaking, a denial of such test-
ing as a matter of policy. The view of Dietrich et al. [2] is
therefore, not a prescription for better information but a
prescription for dramatically less information relative to
the enormous task at hand.
Conflicts of interest
Whatever the course of action, there will be trade-offs.
Policy decisions are not just about a simple balancing of
risks and benefits. Usually the risks fall disproportionately
on those who do not accrue the most benefits. In such a
setting, conflicting goals are to be expected and it is in just
such a setting that transparency about conflicts of interest
becomes paramount. Editors of science journals should be
beyond such conflicts, and their decisions on their col-
leagues’ manuscripts should be neutral and impartial. We
realize that this is not necessarily always the case [9], but
any deviation from the ideal should at least be transparent
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international recommendations on conflict of interest dec-
larations in regard to authors, reviewers, and editors [10].
At least this is what the journal websites say. But precisely
because conflicts mean that there could be an interest in
keeping them secret, we don’t know how often conflicts of
interest are hidden in violation of the formal journal
policies.
In July of this year, a court case revealed that the four in-
dependent laboratories who contributed to a peer-reviewed
article in one of the toxicology journals may not have been
as independent as the publication suggested [11]. The paper
aimed at documenting the lack of endocrine disrupting
properties of a plastic material. The authors declared no
conflict of interest and there was no Acknowledgement sec-
tion in the article. When the scientific methods and inter-
pretation were challenged by a competing company it was
revealed that the producer of the chemical in question had
designed the study, paid the first author to generate the
manuscript and covered all expenses by the participating la-
boratories. This information was withheld from the reader.
In our view, this is a serious breach of trust between au-
thors, editors, and readers. Readers of science publications
and books should know who initiated the science, who paid
for it, and who wrote the manuscript. It may be that this in-
formation is of no consequence, but accepted practice dic-
tates that it be disclosed, while hiding it suggests that there
could be something unsavory going on.
Unfortunately, since the information is withheld it is es-
pecially difficult to find out how often this occurs. Some
insight into hidden conflicts of interest stems from docu-
ments obtained at trials, particularly those involving to-
bacco companies or drug companies [12]. In some recent
articles on asbestos, authors erroneously indicated that
their research was supported by a “grant” from a particular
company, suggesting that the researchers had independence
to explore the research questions [13]. In reality, several
publications were funded by hourly honoraria for consult-
ing services, and manuscripts were drafted by company
employees before co-authors were approached. An appel-
late court opinion in June of 2013 referred to this practice
as potentially being criminally fraudulent [14]. A total of
eleven articles with misleading statements on conflicts of
interest appeared in four different journals that scientists in
the field would consider reputable sources. One toxicology
journal that published four of the articles released “Corri-
genda” [15] and clarified that one author was employed by
a company with direct interest in the results and that “other
authors are consulting experts retained by or on behalf of
[the company] to conduct the research and prepare the ar-
ticles.” This carefully worded text still leaves the readers in
the dark about who did what and how the company inter-
ests affected the research. Perhaps the reviewers and editors
were also misled. None of the articles has been retracted.The portfolio of the publisher of the journal in ques-
tion also includes another toxicology journal where one
of us (PG) served for many years on the editorial board.
Last year, the journal published several articles timed to
coincide with regulatory initiatives regarding endocrine
disruptors and other human health hazards with a clear
bias toward industry interests, thus provoking a discussion
on conflicts of interest. The publisher offered to conduct a
thorough review of all manuscript authors and reviewers
to determine whether a bias was present. However, the
publisher failed to act on the promise, resulting in an end
to a long-term collaboration.
In general terms, a conflict of interest exists when an
author “has financial or personal relationships that in-
appropriately influence (bias) his or her actions”. Although
remedies exist to close a widespread credibility gap with
industry-sponsored research, they are meaningful only in
connection with transparency. The problem of hidden
agendas has magnified as the power of science to legitim-
ate regulation of pollutants has become more obvious and
academic research increasingly dependent on industry
support [16]. Thus, science has now become part of a war,
although most of the battles are fought behind the scenes.
We emphasized in our recent Editorial [17] that trust is
essential in research. While we have accepted practices in
place to minimize undisclosed conflicts, we remain vigilant
because the recent events regarding concealed conflicts of
interest suggest that we may not receive the full informa-
tion about potential conflicts. We are aware of only a single
case where a paper published in Environmental Health had
a potential undeclared conflict. In that instance, an imme-
diate correction was published. We believe that open peer
review and open access provide additional safeguard, as
readers have access to the peer reviews and information on
possible conflicts of interest among both authors and peer
reviewers. But it is no guarantee and we will continue to be
on the alert.
Trust is also a necessary condition, upon which the links
between scientists, journal editors, reviewers, publishers,
and, ultimately, the public rely. Perhaps it was an oversight,
or perhaps Dietrich et al. believe that editors do not need
to provide statements on conflicts of interest. Their editor-
ial [2] did not include any statement on Competing Inter-
ests that might have elucidated whether they have personal
conflicts that would be affected by potential European
Commission decisions they have taken so much time and
effort to oppose even before they have been enacted. We
urge Dietrich et al. to correct that lapse.
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